Cargando…
A Modified Adenovirus Vector–Mediated Antibody Screening Method Identifies EphA2 as a Cancer Target()
BACKGROUND: We constructed a genetically modified adenovirus vector incorporating an IgG Fc-binding motif from staphylococcal protein A, Z33 (Adv-FZ33). Adv-FZ33 allows an antibody to redirect the vector to a target molecule on the cell surface. We attempted to search for target antigen candidates a...
Autores principales: | Tanaka, Toshihiro, Yamada, Hiromi, Kuroki, Masahide, Kodama, Shohta, Tamura, Kazuo, Takamatsu, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430157/ https://www.ncbi.nlm.nih.gov/pubmed/28505517 http://dx.doi.org/10.1016/j.tranon.2017.04.001 |
Ejemplares similares
-
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020) -
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004) -
Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020) -
The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)